Stock Events

Stock Events

Bioton. 

zł0
6
+zł0+0% Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30JanExpected
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q3 2025
Q4 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-7.54%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
415.53MRevenue
-31.32MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0DTR.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap182.6B
Novo Nordisk is a leading global healthcare company that also specializes in diabetes care, directly competing with Bioton in the insulin market.
Sanofi
SNY
Mkt Cap112.08B
Sanofi produces insulin and other diabetes treatments, competing directly in the same therapeutic areas as Bioton.
Lilly(Eli) &
LLY
Mkt Cap789.69B
Eli Lilly is a major player in the production of insulin and diabetes care products, positioning it as a direct competitor to Bioton.
Merck
MRK
Mkt Cap276.38B
Merck & Co., known for its wide range of pharmaceutical products, including diabetes care, competes in the same market as Bioton.
Novartis
NVS
Mkt Cap280.79B
Novartis is involved in the manufacture of drugs that treat various chronic diseases, including diabetes, competing with Bioton's products.
Astrazeneca
AZN
Mkt Cap294.17B
AstraZeneca produces several diabetes medications, making it a competitor in the diabetes care market where Bioton operates.
Takeda Pharmaceutical
TAK
Mkt Cap52.54B
Takeda Pharmaceutical Company provides a range of healthcare solutions including diabetes care, competing in the same space as Bioton.
Abbott Laboratories
ABT
Mkt Cap158.36B
Abbott Laboratories, while known for a broader range of medical devices and diagnostics, also competes in the diabetes care market affecting Bioton's business.

About

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
Show more...
CEO
ISIN
PLBIOTN00029

Listings

STU
DE
7U5.STU
F
DE
7U5.F
WA
PL
BIO.WA
LSE
GB
0DTR.LSE

0 Comments

Share your thoughts

FAQ

What is Bioton. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bioton. stocks are traded under the ticker 0DTR.LSE.
What is Bioton. revenue for the last year?▼
Bioton. revenue for the last year amounts to 415.53M PLN.
What is Bioton. net income for the last year?▼
0DTR.LSE net income for the last year is -31.32M PLN.
In which sector is Bioton. located?▼
Bioton. operates in the Other sector.
When did Bioton. complete a stock split?▼
The last stock split for Bioton. was on January 13, 2014 with a ratio of 1:100.